High-resolution bacterial 16S rRNA gene profile meta-analysis and biofilm status reveal common colorectal cancer consortia.

Drewes JL, White JR, Dejea CM, Fathi P, Iyadorai T, Vadivelu J, Roslani AC, Wick EC, Mongodin EF, Loke MF, Thulasi K, Gan HM, Goh KL, Chong HY, Kumar S, Wanyiri JW, Sears CL. · 2017

Read High-resolution bacterial 16S rRNA gene profile meta-analysis and biofilm status reveal common colorectal cancer consortia. by Drewes JL, White JR, Dejea CM, Fathi P, Iyadorai T, Vadivelu J, Roslani AC, Wick EC, Mongodin EF, Loke MF, Thulasi K, Gan HM, Goh KL, Chong HY, Kumar S, Wanyiri JW, Sears CL. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5707393.txt.

Introduction

Drewes and co-authors pool many studies to find shared microbes in colorectal cancer. Their work combines a new patient group from Malaysia with eleven public datasets. Colorectal cancer is the third most common cancer in the world. Past studies tied gut microbes to the disease, but few links held across studies.

The team used fine-grained 16S rRNA gene profiling and checked for biofilms. Cancer tissues held more invasive biofilms, mostly on right-sided tumors. Certain bacteria turned up again and again across datasets. These included Bacteroides fragilis and several oral pathogens. Species from the mouth as a group were strongly enriched. No single feature appeared in all cases, but overlap was high.

Catalog record

CREATORDrewes JL, White JR, Dejea CM, Fathi P, Iyadorai T, Vadivelu J, Roslani AC, Wick EC, Mongodin EF, Loke MF, Thulasi K, Gan HM, Goh KL, Chong HY, Kumar S, Wanyiri JW, Sears CL.
YEAR2017
COLLECTIONPAPERS
FORMATTXT
FILE SIZE60 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5707393

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

High-resolution bacterial 16S rRNA gene profile meta-analysis and biofilm status reveal common colorectal cancer consortia By Julia L. Drewes, James R. White, Christine M. Dejea, Payam Fathi, Thevambiga Iyadorai, Jamuna Vadivelu, April C. Roslani, Elizabeth C. Wick, Emmanuel F. Mongodin, Mun Fai Loke, Kumar Thulasi, Han Ming Gan Published in: NPJ Biofilms and Microbiomes DOI: 10.1038/s41522-017-0040-3 ABSTRACT Colorectal cancer (CRC) remains the third most common cancer worldwide, with a growing incidence among young adults. Multiple studies have presented associations between the gut microbiome and CRC, suggesting a link with cancer risk. Although CRC microbiome studies continue to profile larger patient cohorts with increasingly economical and rapid DNA sequencing platforms, few common associations with CRC have been identified, in part due to limitations in taxonomic resolution and differences in analysis methodologies. Complementing these taxonomic studies is the newly recognized phenomenon that bacterial organization into biofilm structures in the mucus layer of the gut is a consistent feature of right-sided (proximal), but not left-sided (distal) colorectal cancer. In the present study, we performed 16S rRNA gene amplicon sequencing and biofilm quantification in a new cohort of patients from Malaysia, followed by a meta-analysis of eleven additional publicly available data sets on stool and tissue-based CRC microbiota using Resphera Insight, a high-resolution analytical tool for species-level characterization. Results from the Malaysian cohort and the expanded meta-analysis confirm that CRC tissues are enriched for invasive biofilms (particularly on right-sided tumors), a symbiont with capacity for tumorigenesis (Bacteroides fragilis), and oral pathogens including Fusobacterium nucleatum, Parvimonas micra, and Peptostreptococcus stomatis. Considered in aggregate, species from the Human Oral Microbiome Database are highly enriched in CRC. Although no detected microbial feature was universally present, their substantial overlap and combined prevalence supports a role for the gut microbiota in a significant percentage (>80%) of CRC cases. INTRODUCTION While numerous environmental risk factors for colorectal cancer (CRC) were established decades ago,1 only in recent years have we begun to appreciate the role of the gut microbiome in CRC. Over a dozen studies have now established that CRC is associated with some form of microbial dysbiosis in terms of taxonomic composition and/or mucosal structural organization (e.g., biofilms), as detected either via stool or tumor tissue.2–16 However, these CRC microbiome profiling studies have yielded inconsistent findings, likely due to differences in study design and analysis methodologies. Furthermore, the relative contribution of mucosal vs. luminal (i.e., stool) populations, known to differ,17 is uncertain. In the present study, we analyzed the taxonomic composition and biofilm status of both previous and new cohorts in order to present a more robust depiction of the contribution of the microbiota to CRC. RESULTS Confirmation of the biofilm-spatial relationship in CRC We first sought to validate previous findings that invasive biofilms are a feature of right-sided (proximal) CRC, originally described in a USA cohort (USA, N = 36) and a Malaysian cohort (MAL1, N = 22).16 Biofilms form when bacteria aggregate on a surface (biological or inert) and become encased in a polymeric matrix.18,19 Similar to other in vivo biofilms including oral biofilms (dental plaque) and Pseudomonas aeruginosa biofilms in cystic fibrosis patients, the colonic biofilm matrix may consist of both host mucus and bacteria-produced extrapolymeric substrates.20,21 The invasion and attachment of biofilms to the colonic epithelium and inner mucus layer can be visualized by a number of different microscopy-based methodologies including fluorescence in situ hybridization (FISH) staining with oligonucleotide fluorescent probes, electron microscopy, or acridine orange staining.22,23 Tumor and paired normal samples from a new cohort of 23 patients in Malaysia who underwent surgical resection (described hereafter as MAL2; see Supplementary Table S1 for metadata) were thus screened by FISH with the Eub338 universal 16S rRNA gene probe, using slides from tissue blocks fixed in Carnoy’s to preserve the mucus layer. Paired normal samples were taken from a non-cancerous region of the resected colorectal sample as far as possible from the tumor itself (Supplementary Fig. S1a). Representative biofilm-positive (right-sided) and biofilm-negative (left-sided) tissues from MAL2 are shown in Fig. 1a. A total of 6/16 left-sided tumors from MAL2 were biofilm positive (37.5%), while all seven right-sided tumors were biofilm positive (100%). Biofilm results for MAL2 were then combined with the previously published USA and MAL1 cohorts.16 The spatial distribution of tumors and their biofilm status for all three cohorts are depicted in Fig. 1b. Individual study tumor maps are shown in Supplementary Fig. S1b. Each study individually had a significantly higher prevalence of biofilms on right-sided tumors by Fisher’s exact test (Fig. 1c; USA p < 0.0001; MAL1 p = 0.029; MAL2 p = 0.008), as did the combined analysis of all three studies (Fig. 1d, p < 0.0001). However, the Malaysian cohorts MAL1 and MAL2 had approximately a 3-fold higher prevalence of biofilms on left-sided tumors than the USA cohort (33% for MAL1, 38% for MAL2, and 12% for USA), which may reflect differences in diet/lifestyle, genetics, or the native microbial environment of the two countries. As previously reported for the USA cohort, the biofilm status of paired normal tissues from MAL1 and MAL2 largely matched the biofilm status of the tumors from the same individual and therefore were called concordant pairs; only 2/21 MAL1 and 3/23 MAL2 patients had discordant biofilm scores between their tumor and normal tissues, all 5 of which were cases in which the tumor was biofilm positive but the paired normal tissue was negative. Multivariate logistic regression analysis revealed that tumor stage [N = 74 cancers, excluding surgical polyps (6 from USA; 1 from MAL1)] was not significantly associated with biofilm status after controlling for tumor side (Fig. 1e, right tumors p > 0.48 for all stages; left tumors p > 0.19 for all stages).Fig. 1Meta-analysis of biofilm prevalence in CRC. a Microbial biofilms in Carnoy’s-fixed tissue were detected by FISH with the universal 16S rRNA gene probe Eub338 (stained in red) and the nucleic acid stain DAPI (blue). White brackets denote the mucus layer, visible via autofluorescence of the tissue. Left panel: a biofilm-positive paired normal tissue from the right colon of a CRC patient with abundant bacteria adjacent to the epithelium (arrow). Right panel: a biofilm-negative paired normal tissue from the left colon of a CRC patient with minimal bacteria (arrow) present only in the outer edge of the mucus. Scale bars represent 100 μm. b The locations of tumors from USA, MAL1, and MAL2 are overlaid on a diagram of the colon. c Percentage of biofilm-positive right and left tumors for the three cohorts. All statistics shown are Fisher’s exact tests. d Total percentage of biofilm-positive right- and left-sided tumors from all three cohorts is depicted with a Fisher’s exact test p-value. e Left-sided and right-sided tumors separated according to tumor stage and biofilm status. Multivariate logistic regression analysis was performed after controlling for tumor side. f, g Biofilm-positive samples were stained with DAPI (blue) and probes against four bacterial membership groups: Fusobacterium (yellow), Bacteroidetes (green), Lachnospiraceae (red), and Proteobacteria (magenta). Scale bars in large images represent 100 μm; scale bars in smaller, inset images represent 5 μm. f Representative polymicrobial biofilm from a tumor (left panel) and its paired normal tissue (right panel), with blooms of Fusobacterium in yellow visible only in the tumor. g Representative

Read the complete text